Literature DB >> 4810076

Homozygous state for Hb Constant Spring (slow-moving Hb X components).

L E Lie-Injo, J Ganesan, J B Clegg, D J Weatherall.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4810076

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Hemoglobin Koya Dora: high frequency of a chain termination mutant.

Authors:  W W De Jong; P Meera Khan; L F Bernini
Journal:  Am J Hum Genet       Date:  1975-01       Impact factor: 11.025

2.  Is haemoglobin G alpha Philadelphia linked to alpha-thalassaemia?

Authors:  C Politis-Tsegos; A Lang; R Stathopoulou; H Lehmann
Journal:  Hum Genet       Date:  1976-01-28       Impact factor: 4.132

Review 3.  The molecular pathology of the alpha globin genes.

Authors:  D J Weatherall; D R Higgs; J B Clegg
Journal:  Br J Cancer Suppl       Date:  1988-12

4.  Imbalance in alpha and beta globin synthesis associated with a hemoglobinopathy.

Authors:  R F Rieder; G W James
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

5.  Mapping the alpha-globin genes in Hb J Mexico carriers.

Authors:  G Trabuchet; F Morle; G Verdier; J Godet; M Benabadji; V M Nigon
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

6.  Hematologic and biosynthetic studies in homozygous hemoglobin Constant Spring.

Authors:  S Derry; W G Wood; M Pippard; J B Clegg; D J Weatherall; S N Wickramasinghe; J Darley; S Fucharoen; P Wasi
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

7.  Genetic and biosynthetic studies of families carrying hemoglobin J alpha Mexico: association of alpha-thalassemia with HbJ.

Authors:  G Trabuchet; M Benabadji; D Labie
Journal:  Hum Genet       Date:  1978-06-09       Impact factor: 4.132

8.  Homozygous haemoglobin Constant Spring: a need for revision of concept.

Authors:  P Pootrakul; P Winichagoon; S Fucharoen; P Pravatmuang; A Piankijagum; P Wasi
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.